$CLVT

CLARIVATE PLC

No enriched coverage for $CLVT in the last 7 days.

No SEC Form 4 filings for $CLVT in the last 30 days.

Med

Clarivate (CLVT) Valuation Check After Launch Of Web Of Science Research Intelligence AI Platform

Clarivate (CLVT) has launched its Web of Science Research Intelligence AI platform, which combines curated data, impact metrics, and workflows for research institutions. Despite this new product, Clarivate's short-term stock performance has been mixed, with a recent decline in its 7-day and year-to-date returns, although its 90-day return is positive. The company's stock is currently trading at a discount to analyst targets and some intrinsic estimates, with a fair value of $4.21 against its current price of $2.42, suggesting it may be undervalued assuming it can achieve sustained profitability.

Analysts’ Opinions Are Mixed on These Technology Stocks: Braze (BRZE), DigitalOcean Holdings (DOCN) and Clarivate (CLVT)

Analysts have issued mixed ratings for several technology stocks including Braze (BRZE), DigitalOcean Holdings (DOCN), and Clarivate (CLVT). Braze received a Strong Buy consensus, with TD Cowen and Needham reiterating Buy ratings at $30 and $50 targets respectively. DigitalOcean Holdings has a Moderate Buy consensus, with William Blair maintaining a Buy rating and TipRanks – DeepSeek upgrading it to Buy with a $110 target. Clarivate holds a Hold consensus, with William Blair and RBC Capital both maintaining Hold ratings.

Clarivate Introduces Nexus Connect, the First Institutional AI Gateway to Trusted Research and Learning

Clarivate Plc has launched Nexus Connect, an AI gateway providing seamless access for students and researchers to university academic resources and services. This platform integrates directly into leading AI chat agents like ChatGPT or Claude, allowing users to access licensed content and library services within their AI workspace. Nexus Connect aims to keep libraries central to research by giving institutions control and visibility over the resources accessed through AI, with an early access program planned for July 2026.